ursodeoxycholic acid has been researched along with Albuminuria in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, AL; Chen, X; Chu, S; Guo, HJ; Liu, C; Peng, W; Wang, L; Wang, YM; Zhang, XM | 1 |
| Lagoo, A; McMurray, RW; Suwannaroj, S | 1 |
2 other study(ies) available for ursodeoxycholic acid and Albuminuria
| Article | Year |
|---|---|
Ursodeoxycholic acid and 4-phenylbutyrate prevent endoplasmic reticulum stress-induced podocyte apoptosis in diabetic nephropathy.
Topics: Albuminuria; Animals; Apoptosis; Autophagy; Cells, Cultured; Diabetic Nephropathies; Endoplasmic Reticulum Stress; Glucose Tolerance Test; Insulin; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Mutation; Phenylbutyrates; Podocytes; Receptors, Leptin; Ursodeoxycholic Acid | 2016 |
Suppression of renal disease and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus (SLE) by chenodeoxycholic acid.
Topics: Albuminuria; Animals; Antibodies, Antinuclear; Blood Urea Nitrogen; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cytokines; Disease Models, Animal; Female; Gastrointestinal Agents; Hemocyanins; Immunization; Immunoglobulin G; Kidney; Liver; Lupus Nephritis; Mice; Mice, Inbred NZB; Spleen; Survival Rate; Uremia; Urodynamics; Ursodeoxycholic Acid | 2001 |